MERIT MEDICAL SYSTEMS INC (MMSI)
Health Care · Medical device manufacturing - interventional and diagnostic systems · NASDAQ
Merit Medical Systems manufactures and markets proprietary medical devices for interventional, diagnostic and therapeutic procedures across cardiology, radiology, oncology, critical care and endoscopy.
What MERIT MEDICAL SYSTEMS INC does
Merit Medical Systems is a leading manufacturer and marketer of proprietary medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. The company operates through two business segments—cardiovascular and endoscopy—organized into two product categories: foundational (including access devices, procedural solutions, OEM products, and vascular intervention) and therapeutic (including cardiac therapies, oncology, renal therapies, vascular intervention, OEM products and endoscopy). The company designs, develops, manufactures and sells through direct sales forces and distributors worldwide, with a focus on customer-centered innovation and facility-specific solutions.
Themes: ["Interventional cardiology","Interventional radiology","Vascular access and hemodialysis","Oncology intervention","Endoscopy","Critical care","Minimally invasive procedures"]
Fundamentals
- Price$71.46 as of 2026-07-09 close
- Market cap$4.2B as of 2026-07-10
- 1-year return-25.6% as of 2026-07-09 close
- P/E30.44 as of 2026-07-10
- Net margin+9.0% as of 2026-07-10
- Gross margin+48.7% as of 2026-07-10
- ROE+8.9% as of 2026-07-10
- Debt / equity0.45 as of 2026-07-10
- Revenue growth (YoY)+11.1% as of 2026-07-10
- Revenue CAGR (3y)+9.6% SEC XBRL
- Beta0.51 as of 2026-07-10
Key risks (from latest filing)
["Dependence on sales growth in domestic and international markets; foreign exchange fluctuations impact reported results and competitive position","Significant uncertainty regarding recovery of tariffs previously imposed under IEEPA; timing and amount of any recovery remain unclear","Reliance on successful integration of recent acquisitions (Biolife's StatSeal and WoundSeal products, Pentax's C2 Cryoballoon) to drive sales growth in foundational and therapeutic segments"]
Competitors & peers
- Boston Scientific (BSX)
- Medtronic (MDT)
- Cook Medical
- Teleflex (TFXC)
- Cordis (a Cardinal Health subsidiary)
- AngioDynamics (ANGO)
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.